Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Amarin Corp. plc
Amarin reports Miraxion improves stress hormone transport
April 8th, 2006
Amarin Corp. plc (AMRN) reported that preclinical data from a study conducted at the University of Valencia, Spain, demonstrates that Miraxion (ultra-pure ethyl-eicosapentaenoic acid (E-EPA)) may improve stress hormone (such as cortisol) transport through the blood brain barrier. The investigation was conducted by professor M.V. Bermejo, Department of Pharmaceutics, University of Valencia. It is expected that the details of this work will be published in a peer reviewed journal. Increased plasma levels of cortisol and overactivity of the hypothalamus-pituitary adrenocortical axis (HPA) are considered to be a cause of melancholic depression. Improved...
Source: Law & Health Weekly (2006-04-08)
|
